IMMP
Immutep Limited
Company Overview
| Mkt Cap | $292.91M | Price | $1.82 |
| Volume | 81.98K | Change | -3.97% |
| P/E Ratio | -6.9 | Open | $1.89 |
| Revenue | -- | Prev Close | $1.89 |
| Net Income | $-42.7M | 52W Range | $1.32 - $2.71 |
| Div Yield | N/A | Target | $9.50 |
| Overall | 42 | Value | -- |
| Quality | 34 | Technical | 50 |
No chart data available
Stock Overview
Updated DailyImmutep Limited (IMMP) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.81 with a market capitalization of $292.91 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows IMMP with a volume of 82K shares. The stock opened down 0.00% from yesterday's close of $1.89. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
IMMP demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including RDUS, ILMN, HTGM, FGEN.
Key investment considerations for IMMP include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 423.4%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 09:12 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMMP | $1.82 | -4.0% | 81.98K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |